St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr

Clinical research at Rheumazentrum Ruhrgebiet in Herne is centered on the management of axial spondyloarthritis, with attention to both established and very early inflammatory disease. The trials reflect interest in symptom control, reduction of disease activity, and treatment strategies for patients who do not respond adequately to initial anti-inflammatory therapy.

• Nonsteroidal anti-inflammatory drugs in outpatient care
• TNF blockers for inflammatory spine disease
• Early intervention in active axial spondyloarthritis

The sponsor also supports research into treatment selection for patients with persistent inflammatory symptoms, including comparative evaluation of biologic therapy and standard anti-inflammatory approaches.